The CDC is urging clinicians to prioritize 100 milligram doses of a new respiratory syncytial virus drug for infants at highest risk of severe disease amid limited supply.
Read the full post on Becker's Hospital Review - Healthcare News
CDC warns clinicians on limited supply of RSV drug
